Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
Claire Mason, Tanmay Kanitkar, Charlotte Richardson, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 5, pp. 1323-1331
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Clark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 8, pp. e354-e365
Open Access | Times Cited: 291
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
Pontus Hedberg, Niclas Johansson, Anders Ternhag, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 70
COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation
Michael J. Patton, Carlos J. Orihuela, Kevin S. Harrod, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 66
Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic
Santiago Grau, Daniel Echeverría-Esnal, Sílvia Gómez-Zorrilla, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 132-132
Open Access | Times Cited: 81
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
Shamshul Ansari, John P. Hays, Andrew H. Kemp, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 79
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications
Jacob Pierce, Michael Stevens
International Journal of Infectious Diseases (2021) Vol. 113, pp. 103-108
Open Access | Times Cited: 51
Diagnostic concordance between BioFire® FilmArray® Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia
Francisco Molina, Luz Elena Botero, Juan Pablo Isaza, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 24
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study
Maddalena Giannella, Matteo Rinaldi, Giulia Tesini, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1243-1253
Open Access | Times Cited: 20
SHEA statement on antibiotic stewardship in hospitals during public health emergencies
Tamar F. Barlam, Mayar Al Mohajer, Jaffar A. Al‐Tawfiq, et al.
Infection Control and Hospital Epidemiology (2022) Vol. 43, Iss. 11, pp. 1541-1552
Open Access | Times Cited: 15
Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
Stephen Hughes, Nabeela Mughal, Luke Moore
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1119-1119
Open Access | Times Cited: 18
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
Maddalena Peghin, Antonio Vena, Elena Graziano, et al.
Therapeutic Advances in Infectious Disease (2022) Vol. 9
Open Access | Times Cited: 12
Community-acquired bacterial coinfections and COVID-19
Michael J. Patton, Amit Gaggar, Matthew Might, et al.
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 1-21
Closed Access | Times Cited: 7
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19
Chiara Robba, Denise Battaglini, Lorenzo Ball, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 10, pp. 1293-1302
Open Access | Times Cited: 16
Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project
С. Н. Авдеев, Svetlana Rachina, Yuliya Belkova, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 5, pp. 75-75
Open Access | Times Cited: 11
Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission
Adrián Antuori, Montserrat Giménez, Guillermo Linares, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Association Between Early Antibiotic Therapy and In-Hospital Mortality Among Older Patients With SARS-CoV-2 Pneumonia
Alain Putot, Kévin Bouiller, Caroline Laborde, et al.
The Journals of Gerontology Series A (2021) Vol. 77, Iss. 4, pp. e115-e123
Open Access | Times Cited: 11
C-reactive protein-guided use of procalcitonin in COVID-19
Rebecca Houghton, Nathan Moore, Rebecca Williams, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 11
Antibacterial agents used in COVID-19: A systematic review and meta-analysis
Swati Sharma, Aradhana Singh, Tuhina Banerjee
Environmental Sustainability (2021) Vol. 4, Iss. 3, pp. 503-513
Open Access | Times Cited: 10
When to Use Antibiotics in COVID-19: A Proposal Based on Questions
Carmelo Dueñas Castell, Camilo Polanco-Guerra, María Cristina Martínez‐Ávila, et al.
Cureus (2022)
Open Access | Times Cited: 6
Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID- 19
Stephen Hughes, Nabeela Mughal, Luke Moore
Research Square (Research Square) (2021)
Open Access | Times Cited: 7
Using risk factors and markers to predict bacterial respiratory co-/superinfections in COVID-19 patients: is the antibiotic steward’s toolbox full or empty?
Johan Van Laethem, Jan Pierreux, Stephanie Wuyts, et al.
Acta Clinica Belgica (2023) Vol. 78, Iss. 5, pp. 418-430
Open Access | Times Cited: 2
Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
Hiromichi S. Park, Caitlin M. McCracken, Noah Lininger, et al.
Infection Control and Hospital Epidemiology (2023) Vol. 44, Iss. 10, pp. 1650-1656
Open Access | Times Cited: 2
Kinetics of C-Reactive Protein and Procalcitonin in the Early Identification of ICU-Acquired Infections in Critically Ill COVID-19 Patients
José Pedro Cidade, Luís Coelho, Pedro Póvoa
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6110-6110
Open Access | Times Cited: 2
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Emmanuel Wey, Clare Bristow, Aarti Nandani, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 607-635
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top